Aurobindo’s subsidiary secures approval for Budesonide Inhalation Suspension
The approved item addresses asthma maintenance and prophylactic therapy in children aged 12 months to eight years.
The approved item addresses asthma maintenance and prophylactic therapy in children aged 12 months to eight years.